What the FDA’s New Gluten Labeling Push Means for CPG Packaging Teams
I was reviewing quotes for a mid-year label run last week — about 500,000 units across five SKUs — when the FDA’s gluten disclosure announcement hit my inbox. My first thought wasn’t about celiac disease or consumer health. It was, “Okay, how many of these SKUs have barley, rye, or oat-derived ingredients that aren’t explicitly called out on our current panels?”
Some background: I manage packaging procurement for a 200-person beverage and snack company. Our annual label budget sits around $1.5 million, spread across a dozen or so suppliers. In eight years of doing this, I’ve learned that regulatory changes don’t start with new plates or inks. They start with a spreadsheet, a lot of internal emails, and a very careful re-read of every ingredient deck we’ve ever approved.
The FDA’s Request for Information (RFI) on gluten labeling, issued in January 2026, is targeting what Health and Human Services Secretary Robert Kennedy Jr. called “radical transparency.” For the 1 in 100 Americans with celiac disease and millions more with gluten sensitivity, this could finally make hidden gluten — lurking in additives, flavorings, or via cross-contact — easier to spot.
For procurement and packaging ops, it’s a looming project that ties directly to cost, timing, and supplier readiness.
The Real Cost Isn’t the Ink — It’s the Requalification
When most people think “label change,” they think about the physical printing. The plate remakes, the new artwork, the press time. In my experience, that’s maybe 30% of the actual cost. The other 70% is the internal requalification process.
Let’s say the FDA eventually mandates clearer disclosure for rye, barley, and oats (the core focus of this RFI). Oats are the tricky one — they’re naturally gluten-free but often contaminated during growing or processing. If we have to call out “oats (may contain gluten)” or something similar for any of our granola or oat-based lines, that triggers a cascade:
- Legal & Compliance Review: Does our current supplier documentation specify gluten-free oat sourcing, or just “oats”?
- R&D/Formulation Check: Are any of our “natural flavors” or “spices” derived from gluten-containing grains? (This happens more than you’d think.)
- Marketing & Brand Messaging: Do we lean into “now with clearer gluten labeling” or quietly update and hope no one notices?
- Supplier Re-quote: A full label redesign, even if it’s just text, means new proofs, new setups. That’s rarely free.
I learned this the expensive way back in 2023 when sesame was added to the major allergen list. We had one SKU with “natural tahini flavor.” The label update itself cost about $1,200. The internal hours spent tracking down the flavor supplier’s documentation, getting legal sign-off, and coordinating with marketing? Closer to $8,500. And we caught it late, which meant a rush fee on the print run.
The Supplier Readiness Gap
Here’s something most compliance articles don’t mention: not all label converters are set up for agile, regulation-driven changes. The big ones with dedicated CPG teams? They’re already sending out client alerts about this RFI. The smaller, regional shops we use for short runs or test products? They’re focused on hitting their press schedules.
After the sesame ruling, one of our backup suppliers took three weeks just to provide a quote for the change — their art department was swamped. We ended up paying a 40% premium to our primary vendor to get it done in the timeline we needed. That’s the hidden contingency cost of regulatory shifts: your supply chain flexibility gets tested, and the inflexible links get expensive.
The FDA’s RFI comment period was originally set to close in late March 2026 but has been extended to April 22, 2026. Over 5,000 comments are already in. That tells me the industry is engaged, but also that there’s a lot of confusion to unpack.
Beyond the “Gluten-Free” Claim
Many brands already use third-party certifications like the Gluten-Free Certification Organization (GFCO) mark, which requires products to test under 10ppm gluten (stricter than the FDA’s 20ppm threshold). That’s a great trust signal for consumers who seek out those products.
But this RFI is about something different: transparency for products that aren’t marketed as gluten-free. It’s about the soup that uses barley malt extract for flavor, or the dressing that uses rye-based vinegar. Right now, someone with celiac disease has to be a detective to find those ingredients. The FDA is asking if that’s good enough.
From a pure procurement standpoint, I have mixed feelings. Clearer labels are objectively better and reduce liability risk. But the transition is messy. Do we proactively redesign labels now based on what the rules might be? That’s wasted money if the final rule is different. Do we wait and risk a compressed, expensive changeover later? That’s what cost us with sesame.
The Pragmatic Next Steps for Packaging Buyers
Based on the last few rounds of allergen labeling updates, here’s my action list for any team managing packaging spend:
- Audit Your “Gray Area” Ingredients: Pull the spec sheets for any product containing oats, rye, barley, or “natural flavors/grain derivatives.” Do your COAs (Certificates of Analysis) mention gluten testing or cross-contact controls? If not, start asking now.
- Talk to Your Primary Label Supplier: Don’t wait. Ask them: “If gluten disclosure rules change in the next 12-18 months, what would our lead time be for a multi-SKU label update? What’s the typical cost structure (setup, plate changes)?” Get it in writing.
- Model the Budget Impact: Run a scenario. If 30% of your SKUs need a text update, and 10% need a full panel redesign, what’s the approximate hit? Build a line item into your 2027 budget draft now. It’s easier to remove later than to beg for emergency funds.
- Watch the GFCO Standard: Even if you don’t certify, the GFCO’s 80-step certification manual is a de facto playbook for gluten control. Their standards often preview where regulatory expectations are headed.
The FDA’s Commissioner, Dr. Marty Makary, said the goal is to stop making people “tiptoe around food” and guess about their options. That’s the right goal. For those of us buying the labels, the goal is to navigate that change without tipping the budget over. It starts with treating this RFI not as a distant regulatory headline, but as a project brief that just landed on your desk. The comment period is still open. The cost of being unprepared, as I’ve learned, always comes due.
